Company Profile
Kiniksa Stock Price, News & Analysis
- Ticker:
- KNSA
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, Kiniksa is followed within the biotech universe for its exposure to catalyst-driven execution.
Stock performance
59.49 USD (+4.13%)
Close
Last updated: June 23, 2026 at 00:00
4.58B USD
Market cap
Why the stock is moving
KNSA is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Kiniksa is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Kiniksa is followed within the biotech universe for its exposure to catalyst-driven execution.
Business Model Characteristics
Kiniksa follows a catalyst-driven model where the market watches how the company turns development work into repeatable value creation.
Position Within the Biotechnology Landscape
Compared with more mature healthcare peers, Kiniksa sits closer to the development side of the biotechnology landscape, where timing around data and approvals matters most.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
- 02
- 03
- 04
- 05
Kiniksa Pharmaceuticals Provides Corporate Update
Source: Kiniksa
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Kiniksa (KNSA)?
Kiniksa (KNSA) most recently closed at 59.49 USD, a +4.13% move versus the previous session.
What is the market cap of Kiniksa (KNSA)?
Kiniksa currently has a market capitalization of 4.58B USD on BioPharmSignal.
What does Kiniksa do?
Kiniksa is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
On which exchange is KNSA stock listed?
Kiniksa (KNSA) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, Kiniksa is followed within the biotech universe for its exposure to catalyst-driven execution., Biotechnology.
What is Kiniksa?
Kiniksa is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs.
Which conditions is Kiniksa targeting with Kiniksa?
Kiniksa is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
What is Investors?
Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.